[1] 马长生. 房颤的流行病学进展[J]. 医学与哲学(B),2016,37(11):8-9,26. [2] WEIGNER M J, CAULFIELD T A, DANIAS P G, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation of less than 48 hours[J]. Ann Intern Med, 1997, 126(8):615-620. [3] PRYSTOWSKY E N, BENSON D W Jr, FUSTER V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association[J]. Circulation, 1996, 93(6):1262-1277. [4] ALBERS G W, DALEN J E, LAUPACIS A, et al. Antithrombotic therapy in atrial fibrillation[J]. Chest, 2001, 119(1 Suppl):194S-206S. [5] WYNN G J, TODD D M, WEBBER M,et al.The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification[J].Europace,2014,16(7): 965-972. [6] GALVE E, RIUS T, BALLESTER R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study[J].J Am Coll Cardiol,1996,27(5):1079-1082. [7] NOC M, STAJER D, HORVAT M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm[J]. Am J Cardiol, 1990, 65(9):679-680. [8] COTTER G, BLATT A, KALUSKI E, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study[J]. Eur Heart J, 1999, 20(24):1833-1842. [9] GELERIS P, STAVRATI A, AFTHONIDIS D, et al. Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation[J]. J Cardiol, 2001, 37(2):103-107. [10] DOYLE B, REEVES M. “Wait and see” approach to the emergency department cardioversion of acute atrial fibrillation[J]. Emerg Med Int, 2011, 2011:545023. [11] CAPUCCI A, COMPAGNUCCI P. Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No[J]. Intern Emerg Med, 2020, 15(1):5-7. [12] CAPRANZANO P, CALVI V. Timing of cardioversion in atrial fibrillation: the sooner the better?[J]. Eur Heart J Suppl, 2020, 22(Suppl L):L41-L43. [13] DUDINK E, ESSERS B, HOLVOET W,et al. Acute cardioversion vs a wait-and-see approach for recent-onset symptomatic atrial fibrillation in the emergency department: Rationale and design of the randomized ACWAS trial[J]. Am Heart J, 2017, 183:49-53. [14] PLUYMAEKERS N A H A, DUDINK E A M P, LUERMANS J G L M. Early or delayed cardioversion in recent-onset atrial fibrillation. Reply[J]. N Engl J Med, 2019, 380(16):1499-1508. [15] BOTTO G L, TORTORA G. Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes[J].Intern Emerg Med, 2020, 15(1):1-4. [16] 董福强,霍宁. 房颤的发病机制研究及其中西医结合治疗进展[J]. 天津中医药, 2021, 38(8):1083-1088. |